MENTOR CAPITAL, INC. (OTCMKTS:MNTR) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

0

MENTOR CAPITAL, INC. (OTCMKTS:MNTR) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02.  Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

On April 14, 2017, Earl Kornbrekke, a director of the registrant resigned.

Mr. Kornbrekke did not have any disagreements with the registrant on any matter relating to the registrant’s operations, policies, or practices.

On April 14, 2017, David G. Carlile, 61, was appointed a director of the registrant.

Mr. Carlile owns 136,008 shares of the registrant’s common stock, and a warrant to purchase up to 2,500 shares of registrant’s common stock at a per share price of $1.60, and has been a significant independent shareholder of registrant for over 17 years. For over 34 years Mr. Carlile has served in Senior Management positions in the coal industry; he has been the President of Carlile Enterprises, Inc. for over 17 years. He received his BSc. in Mining Geology from the Imperial College, University of London in 1977. He also received a Masters Degree in in Mining Engineering from the University of Arizona in 1979.  As with all directors Mr. Carlile will be paid a director meeting fee of $2,000 for each meeting he attends.  On February 13, 2017 Mr. Carlile became a designee and redeemed and immediately exercised 100,000 Series D warrants for 100,000 shares of registrant common stock at $1.70 per share.


About MENTOR CAPITAL, INC. (OTCMKTS:MNTR)

Mentor Capital Inc is a United States-based firm that invests in medical marijuana and recreational use cannabis companies. The Firm has $140 million capital structure and looks like a marijuana fund or cannabis index fund. Its preferred focus is medical and the Company seeks to facilitate the application of cannabis to cancer wasting, calming seizures, Parkinson’s disease, reducing ocular pressures from glaucoma and blunting chronic pain. Its portfolio includes Agenus, Inc, Brighter Day Health, CannaVest, Cel Sci Corp, TBA, Pfizer, Inc, Vical and WCI INC, among others. Effective March 11, 2014, Mentor Capital Inc acquired a 60% interest in Bhang Chocolate Co Inc, a producer of medicated chocolate bars.

MENTOR CAPITAL, INC. (OTCMKTS:MNTR) Recent Trading Information

MENTOR CAPITAL, INC. (OTCMKTS:MNTR) closed its last trading session down -0.05 at 1.65 with 209,400 shares trading hands.